Skip to main content
Top
Published in: Child's Nervous System 6/2016

01-06-2016 | Case Report

Long-term survival of an infant with an atypical teratoid/rhabdoid tumor following subtotal resection and low-cumulative dose chemotherapy: a case report

Authors: Viktor Arnhold, Florian Oyen, Reinhard Schneppenheim, Hannes Haberl, Arend Koch, Michael C. Frühwald, Pablo Hernáiz Driever

Published in: Child's Nervous System | Issue 6/2016

Login to get access

Abstract

Introduction

Atypical teratoid/rhabdoid tumor (AT/RT) is an aggressive embryonal tumor of the central nervous system with a generally dismal prognosis, especially in patients younger than 12 months.

Discussion

We here describe the unusual case of an infant with AT/RT with long-term survival despite low-cumulative dose chemotherapy after subtotal resection. Due to a poor neurological situation and an unfavorable oncological prognosis, therapy was halted after two partial surgical resections and four of the nine chemotherapy courses recommended by the European Rhabdoid Registry, without the patient receiving either radiotherapy or high-dose chemotherapy. The patient is alive without evidence of disease 52 months after diagnosis.

Conclusion

This case report highlights that independent prognostic factors are urgently needed for optimizing treatment stratification and preventing overtreatment.
Literature
1.
go back to reference Hollmann TJ, Hornick JL (2011) INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 35(10):e47–e63CrossRefPubMed Hollmann TJ, Hornick JL (2011) INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 35(10):e47–e63CrossRefPubMed
2.
go back to reference Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11(7):481–492CrossRefPubMed Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11(7):481–492CrossRefPubMed
3.
go back to reference von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N et al (2011) Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57(6):978–985CrossRef von Hoff K, Hinkes B, Dannenmann-Stern E, von Bueren AO, Warmuth-Metz M, Soerensen N et al (2011) Frequency, risk-factors and survival of children with atypical teratoid rhabdoid tumors (AT/RT) of the CNS diagnosed between 1988 and 2004, and registered to the German HIT database. Pediatr Blood Cancer 57(6):978–985CrossRef
4.
go back to reference Woehrer A, Slavc I, Waldhoer T, Heinzl H, Zielonke N, Czech T et al (2010) Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996-2006. Cancer 116(24):5725–5732CrossRefPubMed Woehrer A, Slavc I, Waldhoer T, Heinzl H, Zielonke N, Czech T et al (2010) Incidence of atypical teratoid/rhabdoid tumors in children: a population-based study by the Austrian Brain Tumor Registry, 1996-2006. Cancer 116(24):5725–5732CrossRefPubMed
5.
go back to reference Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA et al (2014) Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012. Cancer Med 3(1):91–100CrossRefPubMedPubMedCentral Slavc I, Chocholous M, Leiss U, Haberler C, Peyrl A, Azizi AA et al (2014) Atypical teratoid rhabdoid tumor: improved long-term survival with an intensive multimodal therapy and delayed radiotherapy. The Medical University of Vienna Experience 1992–2012. Cancer Med 3(1):91–100CrossRefPubMedPubMedCentral
6.
go back to reference Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M et al (2014) Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer 61(1):95–101CrossRefPubMed Zaky W, Dhall G, Ji L, Haley K, Allen J, Atlas M et al (2014) Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly-diagnosed with central nervous system atypical teratoid/rhabdoid tumors: the Head Start III experience. Pediatr Blood Cancer 61(1):95–101CrossRefPubMed
7.
go back to reference Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S et al (2014) Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors—experience of the EU-RHAB registry. Klin Padiatr 226(3):143–148CrossRefPubMed Seeringer A, Bartelheim K, Kerl K, Hasselblatt M, Leuschner I, Rutkowski S et al (2014) Feasibility of intensive multimodal therapy in infants affected by rhabdoid tumors—experience of the EU-RHAB registry. Klin Padiatr 226(3):143–148CrossRefPubMed
8.
go back to reference Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel PG, Witt O et al (2014) High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB). Bone Marrow Transplant 49(3):370–375CrossRefPubMed Benesch M, Bartelheim K, Fleischhack G, Gruhn B, Schlegel PG, Witt O et al (2014) High-dose chemotherapy (HDCT) with auto-SCT in children with atypical teratoid/rhabdoid tumors (AT/RT): a report from the European Rhabdoid Registry (EU-RHAB). Bone Marrow Transplant 49(3):370–375CrossRefPubMed
9.
go back to reference Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA et al (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27(3):385–389CrossRefPubMedPubMedCentral Chi SN, Zimmerman MA, Yao X, Cohen KJ, Burger P, Biegel JA et al (2009) Intensive multimodality treatment for children with newly diagnosed CNS atypical teratoid rhabdoid tumor. J Clin Oncol 27(3):385–389CrossRefPubMedPubMedCentral
10.
go back to reference Finkelstein-Shechter T, Gassas A, Mabbott D, Huang A, Bartels U, Tabori U et al (2010) Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 32(5):e182–e186CrossRefPubMed Finkelstein-Shechter T, Gassas A, Mabbott D, Huang A, Bartels U, Tabori U et al (2010) Atypical teratoid or rhabdoid tumors: improved outcome with high-dose chemotherapy. J Pediatr Hematol Oncol 32(5):e182–e186CrossRefPubMed
11.
go back to reference Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC et al (2012) Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system. J Korean Med Sci 27(2):135–140CrossRefPubMedPubMedCentral Park ES, Sung KW, Baek HJ, Park KD, Park HJ, Won SC et al (2012) Tandem high-dose chemotherapy and autologous stem cell transplantation in young children with atypical teratoid/rhabdoid tumor of the central nervous system. J Korean Med Sci 27(2):135–140CrossRefPubMedPubMedCentral
12.
go back to reference Bouvier C, De Paula AM, Fernandez C, Quilichini B, Scavarda D, Gentet JC et al (2008) Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy. Childs Nerv Syst 24(1):143–147CrossRefPubMed Bouvier C, De Paula AM, Fernandez C, Quilichini B, Scavarda D, Gentet JC et al (2008) Atypical teratoid/rhabdoid tumour: 7-year event-free survival with gross total resection and radiotherapy in a 7-year-old boy. Childs Nerv Syst 24(1):143–147CrossRefPubMed
13.
go back to reference Gidwani P, Levy A, Goodrich J, Weidenheim K, Kolb EA (2008) Successful outcome with tandem myeloablative chemotherapy and autologous peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 88(2):211–215CrossRefPubMed Gidwani P, Levy A, Goodrich J, Weidenheim K, Kolb EA (2008) Successful outcome with tandem myeloablative chemotherapy and autologous peripheral blood stem cell transplants in a patient with atypical teratoid/rhabdoid tumor of the central nervous system. J Neurooncol 88(2):211–215CrossRefPubMed
14.
go back to reference Modena P, Sardi I, Brenca M, Giunti L, Buccoliero AM, Pollo B et al (2013) Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor. BMC Cancer 13:100CrossRefPubMedPubMedCentral Modena P, Sardi I, Brenca M, Giunti L, Buccoliero AM, Pollo B et al (2013) Case report: long-term survival of an infant syndromic patient affected by atypical teratoid-rhabdoid tumor. BMC Cancer 13:100CrossRefPubMedPubMedCentral
15.
go back to reference Dufour C, Beaugrand A, Le Deley MC, Bourdeaut F, Andre N, Leblond P et al (2012) Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 118(15):3812–3821CrossRefPubMed Dufour C, Beaugrand A, Le Deley MC, Bourdeaut F, Andre N, Leblond P et al (2012) Clinicopathologic prognostic factors in childhood atypical teratoid and rhabdoid tumor of the central nervous system: a multicenter study. Cancer 118(15):3812–3821CrossRefPubMed
16.
go back to reference Bourdeaut F, Lequin D, Brugieres L, Reynaud S, Dufour C, Doz F et al (2011) Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 17(1):31–38CrossRefPubMed Bourdeaut F, Lequin D, Brugieres L, Reynaud S, Dufour C, Doz F et al (2011) Frequent hSNF5/INI1 germline mutations in patients with rhabdoid tumor. Clin Cancer Res 17(1):31–38CrossRefPubMed
17.
go back to reference Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65(5):1342–1348CrossRefPubMedPubMedCentral Sevenet N, Sheridan E, Amram D, Schneider P, Handgretinger R, Delattre O (1999) Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Am J Hum Genet 65(5):1342–1348CrossRefPubMedPubMedCentral
18.
go back to reference Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L et al (2015) Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. Lancet Oncol 16(5):569–582CrossRefPubMed Torchia J, Picard D, Lafay-Cousin L, Hawkins CE, Kim SK, Letourneau L et al (2015) Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis. Lancet Oncol 16(5):569–582CrossRefPubMed
Metadata
Title
Long-term survival of an infant with an atypical teratoid/rhabdoid tumor following subtotal resection and low-cumulative dose chemotherapy: a case report
Authors
Viktor Arnhold
Florian Oyen
Reinhard Schneppenheim
Hannes Haberl
Arend Koch
Michael C. Frühwald
Pablo Hernáiz Driever
Publication date
01-06-2016
Publisher
Springer Berlin Heidelberg
Published in
Child's Nervous System / Issue 6/2016
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-015-2999-5

Other articles of this Issue 6/2016

Child's Nervous System 6/2016 Go to the issue